Alendronate Sodium

CAS 121268-17-5 14 current records 10 historicalSmall Molecule

Who holds supplier records for Alendronate Sodium? 14 organisations hold a current record for Alendronate Sodium: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (9), Poland (1), Canada (1), Hungary (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Alendronate Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/alendronate-sodium

Reading the evidence

  • 14 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    9 of the 13 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (14)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Alendronate Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

India9Poland1Canada1Hungary1Spain1Country not recorded for 1
Need Alendronate Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Alendronate Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 15 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Starogard GdanskiPL
CEP 2003-273 - Rev 05
Sodium alendronate trihydrate, Standard, milled and micronised
Jul 2026Inspected Jul 2026
Poland
JUBILANT BIOSYS LIMITED MysuruIN
CEP 2011-111 - Rev 02
Sodium alendronate trihydrate
Mar 2026—
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2008-090 - Rev 03
Sodium alendronate trihydrate
Oct 2025—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2009-290 - Rev 03
Sodium alendronate trihydrate
Oct 2025—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2007-048 - Rev 03
Sodium alendronate trihydrate
Feb 2025—
CADILA PHARMACEUTICALS LIMITED AnkleshwarIN
R1-CEP 2008-230 - Rev 04
Sodium alendronate trihydrate
Sept 2022—
GEDEON RICHTER PLC. BudapestHU
R1-CEP 2004-095 - Rev 04
Sodium alendronate trihydrate, Milled
Aug 2020—
CIPLA LIMITED MumbaiIN
R1-CEP 2005-126 - Rev 04
Sodium alendronate trihydrate
Aug 2018—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2008-192 - Rev 01
Sodium alendronate trihydrate
Jun 2018—
Medichem, S.A. Sant Joan DespíES
R1-CEP 2010-273 - Rev 00
Sodium alendronate trihydrate
Oct 2016—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (10)

Organisations whose Type II DMFs for Alendronate Sodium are no longer active. These show a past filing, not current supply.

Show all 10 historical records
  • India · Inactive DMF 25828 · filed Mar 2012
  • CHONGQING CARE LIFE PHARMACEUTICAL CO LTD
    Inactive DMF 23169 · filed Sept 2009
  • Argentina · Inactive DMF 22733 · filed Apr 2009
  • India · Inactive DMF 20651 · filed Jun 2007
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 20443 · filed Apr 2007
  • EOS ECZACIBASI OZGUN KIMYASAL URUNLER SANAYI VE TICARET AS
    Inactive DMF 20276 · filed Feb 2007
  • Italy · Inactive DMF 15858, 19934 · filed Nov 2006
  • India · Inactive DMF 19299 · filed Mar 2006
  • SIGNA SA DE CV
    Inactive DMF 16129 · filed Sept 2002
  • ALCHYMARS SPA
    Inactive DMF 14983 · filed Aug 2000

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Alendronate Sodium is a bisphosphonate used to prevent and treat osteoporosis in postmenopausal women and in men. It works by inhibiting osteoclast-mediated bone resorption, thus strengthening bone structure.

Chemical identity

IUPAC name
sodium;(4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate;trihydrate
Canonical SMILES
C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.O.O.O.[Na+]
InChIKey
DCSBSVSZJRSITC-UHFFFAOYSA-M
Synonyms
Fosamax API, adrovance, alendronate (as sodium), alendronate sodium hydrate, alendronate sodium trihydrate, alendronic acid (as alendronate sodium), fosamax, fosavance, g-704,650, g-704650, mk-217, nsc-722597

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Bisphosphonate
Chemical structure
Diphosphonates

Therapeutic areas

OsteoporosisBone Density Conservation Agents

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Alendronate Sodium?

14 organisations hold an active US FDA Type II Drug Master File or a CEP for Alendronate Sodium: APITORIA PHARMA PRIVATE LTD (India), Cipla Limited (India), Dr. Reddy's Laboratories Ltd. (India), Ipca Laboratories Limited (India), JUBILANT BIOSYS LTD (India), MATRIX PHARMACORP PRIVATE LTD (India), Zakłady Farmaceutyczne Polpharma S.A. (Poland) and Apotex Inc. (Canada), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Alendronate Sodium Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 20031), Cipla Limited (DMF 14334), Dr. Reddy's Laboratories Ltd. (DMF 20100), Ipca Laboratories Limited (DMF 21008), JUBILANT BIOSYS LTD (DMF 22333), MATRIX PHARMACORP PRIVATE LTD (DMF 20402), Zakłady Farmaceutyczne Polpharma S.A. (DMF 16962) and Apotex Inc. (DMF 15409) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Alendronate Sodium records mean?

10 organisations have only inactive Type II DMFs for Alendronate Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Alendronate Sodium have a European Certificate of Suitability?

Yes. 10 organisations hold a valid CEP for Alendronate Sodium on the EDQM register, including ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdanski (PL), JUBILANT BIOSYS LIMITED Mysuru (IN), IPCA LABORATORIES LIMITED Mumbai (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and CADILA PHARMACEUTICALS LIMITED Ankleshwar (IN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Alendronate Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Alendronate Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.